Navigation Links
Penn study finds elderly heart patients with ICD devices live longer after heart failure
Date:4/30/2008

WASHINGTON, D.C. Elderly patients diagnosed with congestive heart failure who receive implantable cardioverter-defibrillators (ICDs) for primary prevention of sudden cardiac death live longer than those that do not, according to researchers at the University of Pennsylvanias School of Medicine. Further, the health care costs associated with ICDs, while substantial at the time of implantation, do not greatly increase downstream health care costs in this population. The study is among the first to analyze the health outcomes and costs associated with primary prevention ICDs for patients outside of a clinical trial setting.

Researchers examined health care data from a nationally representative sample of 14,250 Medicare beneficiaries over age 66 who were treated for congestive heart failure at over 2,000 academic and community hospitals nationwide. Peter Groeneveld, M.D., M.S., Assistant Professor of General Internal Medicine, and his co-authors reported their findings in the May 2008 issue of the journal Heart Rhythm.

Researchers found that, on average, patients receiving ICDselectric monitoring devices that deliver a lifesaving shock to the heartfor primary prevention had a 38 percent lower mortality rate than patients who did not. Thirteen percent of patients who received ICDs died in the first year after implantation, compared with 23 percent of patients who did not receive ICDs. During the second year, the gap widened, as 17 percent of ICD recipients died, compared with 29 percent who did not receive the device.

According to the study, the average cost for ICD recipients in the first 30 days after initial hospitalization was about $42,000 more than for patients who received other treatments for congestive heart failure, which is comparable to cost estimates from previous clinical studies. Excluding the costs of implantation, after six months the total health care costs for ICD recipients were approximately $1,700 higher than for patients who did not receive an ICD. However, after six months, the health care costs associated with both patient groups were almost identical.

Sudden cardiac arrest is a leading cause of death in the United States, ending the life of about 350,000 Americans each year. In recent years, landmark clinical trials have shown ICDs to be effective in preventing death from cardiac arrest. Subsequently, in 2005 Medicare and other health payers expanded coverage of the device for primary prevention purposes, that is, for patients with heart disease at greater risk of sudden death, but who have not yet experienced heart stoppage. Over 75,000 ICD implants were performed in the United States in 2005.

According to Dr. Groeneveld, while ICDs are among the most common cardiac devices used in contemporary clinical practice, their impact on survival rates and health care costs in non-experimental settings have not been well defined. This study confirms, through real-world experience among thousands of patients, what clinical trials among hundreds of patients found, which is that ICDs enable patients to live longer, at a reasonable cost to society, said Groeneveld.

Primary prevention patients are the largest and fastest growing segment of the ICD patient population. As the Baby Boomer generation ages, hundreds of thousands of patients nationwide may become clinically eligible for and may benefit from an ICD, said Groeneveld.

The findings show that the overall economic value delivered by the ICD is acceptable by U.S. standards for health care expenditures, further substantiating Medicares decision to expand coverage of ICDs for primary prevention patients, said Groeneveld. This is particularly relevant to policy-makers, health care providers and payers who face difficult decisions about the use of innovative medical technology in the face of rising health care costs.


'/>"/>

Contact: Robyn Stein
Robyn.Stein@gabbe.com
212-220-4444
InHealth: The Institute for Health Technology Studies
Source:Eurekalert

Related medicine news :

1. Penn study finds pro-death proteins required to regulate healthy immune function
2. New study shows promise in reducing surgical risks associated with surgical bleeding
3. Study, meta-analysis examine factors associated with death from heatstroke
4. Study suggests loss of 2 types of neurons -- not just 1 -- triggers Parkinsons symptoms
5. Study says COPD testing is not measuring up
6. Preclinical study suggests organ-transplant drug may aid in lupus fight
7. Ability to cope with stress can increase good cholesterol in older white men, study finds
8. High alcohol consumption increases stroke risk, Tulane study says
9. Mailman School of Public Health study examines link between racial discrimination and substance use
10. Pitt study finds inequality in tobacco advertising
11. Stanford study highlights cost-effective method of lowering heart disease risks
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... ... Quality metrics are proliferating in cancer care, and are derived from many ... the beholder, according to experts who offered insights and commentary in the current issue ... the full issue, click here . , For the American Society of Clinical ...
(Date:6/26/2016)... ... , ... PawPaws brand pet supplements owned by Whole Health Supply ... health of felines. The formula is all-natural and is made from Chinese herbs that ... Cat Kidney Support Supplement Soft Chews are Astragalus Root Extract and Rehmannia Root ...
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from the American ... Annual Research Meeting June 26-28, 2016, at the Hynes Convention Center in Boston. ... including advance care planning, healthcare costs and patient and family engagement. , AIR ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand ... project," said Christina Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s ... within Final Cut Pro X . Simply select a ProHand generator and drag ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin ... injury. Recently, he has implemented orthobiologic procedures as a method for treating his ... of the first doctors to perform the treatment. Orthobiologics are substances that orthopaedic ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 2016 According to a new ... Pen Needles, Safety Pen Needles), Needle Length (4mm, 5mm, ... Mode of Purchase (Retail, Non-Retail) - Trends & Global ... the market for the forecast period of 2016 to ... Billion by 2021 from USD 1.65 Billion in 2016, ...
(Date:6/24/2016)... Tenn. , June 24, 2016  Arkis ... providing less invasive and more durable cerebrospinal fluid ... in funding.  The Series-A funding is led by ... Lighthouse Fund, and other private investors.  Arkis, new ... neurosurgical instrumentation and the market release of its ...
(Date:6/23/2016)... -- Any dentist who has made an implant supported denture ... of them do not even offer this as a viable ... costs involved. And those who ARE able to offer that ... cost that the majority of today,s patients would not be ... , founder of Dental Evolutions Inc. and inventor of Implanova ...
Breaking Medicine Technology: